2018
Phthalate Metabolites and Postmenopausal Breast Cancer Risk
Reeves K, Diaz S, Hankinson, Bigelow C, Zoeller, Manson J, Spiegelman D, Tinker L. Phthalate Metabolites and Postmenopausal Breast Cancer Risk. Cancer Epidemiology Biomarkers & Prevention 2018, 27: 355-355. DOI: 10.1158/1055-9965.epi-18-0052.Peer-Reviewed Original ResearchBreast cancer riskPhthalate metabolitesCancer riskWomen’s Health Initiative prospective cohortMultivariable conditional logistic regression analysisConditional logistic regression analysisHuman breast cancer riskIndividual phthalate metabolitesBody mass indexMono-2-ethylhexyl phthalateAnimal model evidenceCase-control studyHuman breast milkLogistic regression analysisRace/ethnicityProspective cohortSmoking statusEnrollment dateMass indexBreast milkProspective dataRisk ratioStudy groupMonoethyl phthalateResults Overall
1999
Rationale and Design of the Tanzania Vitamin and HIV Infection Trial
Fawzi W, Msamanga G, Spiegelman D, Urassa E, Hunter D. Rationale and Design of the Tanzania Vitamin and HIV Infection Trial. Contemporary Clinical Trials 1999, 20: 75-90. PMID: 10027501, DOI: 10.1016/s0197-2456(98)00045-2.Peer-Reviewed Original ResearchConceptsHIV infectionVitamin APregnant womenPolymerase chain reactionVitamin supplementsHIV-positive pregnant womenVertical transmissionHIV Infection TrialInfant immune functionEligible pregnant womenPlacebo-controlled trialClinical staging systemHIV-positive womenGenital tract secretionsUse of supplementsHIV diseaseMost HIVPrevention trialsViral loadMain endpointBreast milkStaging systemCohort retentionPosttest counselingTract secretions